Reckless J P
School of Postgraduate Medicine, University of Bath, Royal United Hospital, England.
Pharmacoeconomics. 1994 Oct;6(4):310-23. doi: 10.2165/00019053-199406040-00002.
Coronary heart disease (CHD) is the major cause of morbidity and mortality in the Western world, and contributes substantially to global healthcare costs. As pressure rises to certain health costs, it is essential to consider the cost-effectiveness of different management strategies. In terms of CHD, treatment costs for different procedures for existing disease can be considered, and can also be compared with the costs of prevention programmes.
冠心病（CHD）是西方世界发病和死亡的主要原因，并且在全球医疗费用中占相当大的比例。随着控制医疗费用的压力增大，考虑不同管理策略的成本效益至关重要。就冠心病而言，可以考虑现有疾病不同治疗方法的治疗成本，也可以将其与预防项目的成本进行比较。
